CRMD

CorMedix Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-05

Figures on this page computed 2026-11-08 13:00 UTC

Last close

5.66USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-05

2.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-05
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
The filing itself
52.3%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
55.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

7.86x

-19.87x

-22.79x

n/a

0.91x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-05

Sales7.86x
Its own average over 9 years, 39.7M.
Profit-19.87x
Its own average over 10 years, -8.2M.
Free cash flow-22.79x
Its own average over 10 years, -7.6M.
Debtn/a
Its own average over 9 years, 1.1M.
Price0.91x
Its own average over 11 years, 6. Market data, 2026-11-04

Free cash flow is furthest from its own average, at -22.79 times.

Sales is 7.86 times its own 9-year average; Profit is -19.87 times its own 10-year average; Free cash flow is -22.79 times its own 10-year average; Price is 0.91 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-05

Sales against its own 9-year average7.86
Source
filed
Statement
income
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
The filing itself
Profit against its own 10-year average-19.87
Source
filed
Statement
income
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
The filing itself
Free cash flow against its own 10-year average-22.79
Source
filed
Statement
income
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
The filing itself
Debt against its own 9-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
The filing itself
Price against its own 11-year average0.91Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD